Online inquiry

IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK0301MR)

This product GTTS-WK0301MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the Intestinal Alkaline Phosphatase protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001631
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 248
UniProt ID P09923
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK0301MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK6263MR IVTScrip™ mRNA-Human LIN2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA LIN2
GTTS-WK18109MR IVTScrip™ mRNA-Human ALDOB, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ALDOB
GTTS-WK28794MR IVTScrip™ mRNA-Human ATP5A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATP5A1
GTTS-WK3238MR IVTScrip™ mRNA-Human PRSS50, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA PRSS50
GTTS-WK19292MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK19588MR IVTScrip™ mRNA-Human ALAS2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALAS2
GTTS-WK14472MR IVTScrip™ mRNA-Human AKR1A1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA AKR1A1
GTTS-WK14012MR IVTScrip™ mRNA-Human ADAR, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAR
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW